FEMY Femasys Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
14:25
Jan 14
Jan 14
Nasdaq extension eases RS fears, good re-entry
Author argues Femasys received a 180-day Nasdaq extension to regain minimum bid price compliance, which alleviates fears of a reverse split that had driven the stock down roughly 33% over the past month. A partnership announced the prior day is cited as an additional positive catalyst. The author views the current ~$0.58 price as a good re-entry point.
HIGH
23:47
Jan 12
Jan 12
Speculative FEMY long on FemBloc catalysts
The author argues FEMY offers an attractive speculative risk/reward near the low end of its recent range after a long pullback, making it preferable to chasing higher prices. The stated catalysts are FemBloc trial and regulatory updates, plus recent financing that extends runway, supported by a women's health med-tech narrative that attracts retail attention on positive news. The author explicitly notes the stock is high risk and not yet profitable, recommending only a small, sized-appropriately speculative position.
HIGH
About FEMY Investor Commentary
Across the available history and selected sources, Buzzberg tracks FEMY (Femasys Inc.) across 1 sources: 2 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/lasairchoille_, u/Ok_Imagination871.